Proteolix

Biopharmaceuticals; Health Care

USVP Contact:
Jon Root , Larry Lasky

Proteolix (acquired by Onyx Pharmaceuticals) is a biopharmaceutical company committed to the discovery, clinical development and marketing of drugs that inhibit the proteasome-mediated protein degradation pathway in cells for the treatment of cancer.

http://www.onyx-pharm.com/